Tumor Antigen LRRC15 Impedes Adenoviral Infection: Implications for Virus-Based Cancer Therapy
J. Virol. O'Prey et al. 82: 5933 Supplemental material
Files in this Data Supplement:
- Supplemental file 1 - Fig. S1 (Expression of the tumor antigen LRRC15 does not affect cell cycle status or cell morphology in Saos-2, HCT-116, and A549 cells.)
PDF file, 764K.